Literature DB >> 15951332

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus.

Mitchell R White1, Erika Crouch, Jenny Vesona, Paul J Tacken, Joseph J Batenburg, Rikke Leth-Larsen, Uffe Holmskov, Kevan L Hartshorn.   

Abstract

Oxidants and neutrophils contribute to lung injury during influenza A virus (IAV) infection. Surfactant protein (SP)-D plays a pivotal role in restricting IAV replication and inflammation in the first several days after infection. Despite its potent anti-inflammatory effects in vivo, preincubation of IAV with SP-D in vitro strongly increases neutrophil respiratory burst responses to the virus. Several factors are shown to modify this apparent proinflammatory effect of SP-D. Although multimeric forms of SP-D show dose-dependent augmentation of respiratory burst responses, trimeric, single-arm forms either show no effect or inhibit these responses. Furthermore, if neutrophils are preincubated with multimeric SP-D before IAV is added, oxidant responses to the virus are significantly reduced. The ability of SP-D to increase neutrophil uptake of IAV can be dissociated from enhancement of oxidant responses. Finally, several other innate immune proteins that bind to SP-D and/or IAV (i.e., SP-A, lung glycoprotein-340 or mucin) significantly reduce the ability of SP-D to promote neutrophil oxidant response. As a result, the net effect of bronchoalveolar lavage fluids is to increase neutrophil uptake of IAV while reducing the respiratory burst response to virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951332     DOI: 10.1152/ajplung.00130.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  25 in total

1.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

Review 2.  Antiviral activities in human saliva.

Authors:  D Malamud; W R Abrams; C A Barber; D Weissman; M Rehtanz; E Golub
Journal:  Adv Dent Res       Date:  2011-04

3.  Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.

Authors:  Karen Ivinson; Georgia Deliyannis; Leanne McNabb; Lara Grollo; Brad Gilbertson; David Jackson; Lorena E Brown
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.

Authors:  Martin van Eijk; Laurie Bruinsma; Kevan L Hartshorn; Mitchell R White; Michael J Rynkiewicz; Barbara A Seaton; Wieger Hemrika; Roland A Romijn; Bas W van Balkom; Henk P Haagsman
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

Review 5.  Preventing and treating secondary bacterial infections with antiviral agents.

Authors:  Jonathan A McCullers
Journal:  Antivir Ther       Date:  2011

6.  A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D.

Authors:  Martin van Eijk; Michael J Rynkiewicz; Mitchell R White; Kevan L Hartshorn; Xueqing Zou; Klaus Schulten; Dong Luo; Erika C Crouch; Tanya R Cafarella; James F Head; Henk P Haagsman; Barbara A Seaton
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

7.  Viral aggregating and opsonizing activity in collectin trimers.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Grith Sorensen; Uffe Holmskov; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

8.  Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice.

Authors:  Cristiana C Garcia; Remo C Russo; Rodrigo Guabiraba; Caio T Fagundes; Rafael B Polidoro; Luciana P Tavares; Ana Paula C Salgado; Geovanni D Cassali; Lirlândia P Sousa; Alexandre V Machado; Mauro M Teixeira
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

9.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

10.  Surfactant protein D protects against acute hyperoxic lung injury.

Authors:  Deepika Jain; Elena N Atochina-Vasserman; Yaniv Tomer; Helchem Kadire; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.